Your browser doesn't support javascript.
loading
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Bianchi, Andrea; De Rimini, Maria Luisa; Sciuto, Rosa; Annovazzi, Alessio; Di Traglia, Silvia; Bauckneht, Matteo; Lanfranchi, Francesco; Morbelli, Silvia; Nappi, Anna Giulia; Ferrari, Cristina; Rubini, Giuseppe; Panareo, Stefano; Urso, Luca; Bartolomei, Mirco; D'Arienzo, Davide; Valente, Tullio; Rossetti, Virginia; Caroli, Paola; Matteucci, Federica; Aricò, Demetrio; Bombaci, Michelangelo; Caponnetto, Domenica; Bertagna, Francesco; Albano, Domenico; Dondi, Francesco; Gusella, Sara; Spimpolo, Alessandro; Carriere, Cinzia; Balma, Michele; Buschiazzo, Ambra; Gallicchio, Rosj; Storto, Giovanni; Ruffini, Livia; Scarlattei, Maura; Baldari, Giorgio; Cervino, Anna Rita; Cuppari, Lea; Burei, Marta; Trifirò, Giuseppe; Brugola, Elisabetta; Zanini, Carolina Arianna; Alessi, Alessandra; Fuoco, Valentina; Seregni, Ettore; Deandreis, Désirée; Liberini, Virginia; Moreci, Antonino Maria; Ialuna, Salvatore; Pulizzi, Sabina; Evangelista, Laura.
Afiliación
  • Bianchi A; Nuclear Medicine Unit, SC Medicina Nucleare, ASO S.Croce e Carle Cuneo, Cuneo, Italy.
  • De Rimini ML; Nuclear Medicine Unit, Department of Health Service, AORN Ospedali dei Colli, Naples, Italy.
  • Sciuto R; Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Annovazzi A; Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Traglia S; Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Bauckneht M; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Lanfranchi F; Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Morbelli S; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Nappi AG; Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ferrari C; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Rubini G; Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Panareo S; Section of Nuclear Medicine, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro," Bari, Italy.
  • Urso L; Section of Nuclear Medicine, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro," Bari, Italy.
  • Bartolomei M; Section of Nuclear Medicine, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro," Bari, Italy.
  • D'Arienzo D; Nuclear Medicine Unit, Oncology and Haematology Department, University Hospital of Modena, Modena, Italy.
  • Valente T; Nuclear Medicine Unit, Oncology and Specialistic Department, University Hospital of Ferrara, Ferrara, Italy.
  • Rossetti V; Nuclear Medicine Unit, Oncology and Specialistic Department, University Hospital of Ferrara, Ferrara, Italy.
  • Caroli P; Nuclear Medicine Unit, Department of Health Service, AORN Ospedali dei Colli, Naples, Italy.
  • Matteucci F; U.O.C. Radiologia, Department of Servizi, AORN Ospedali dei Colli, Napoli, Italy.
  • Aricò D; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori," Meldola, Italy.
  • Bombaci M; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori," Meldola, Italy.
  • Caponnetto D; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori," Meldola, Italy.
  • Bertagna F; Servizio di Medicina Nucleare, Humanitas Istituto Clinico Catanese, Misterbianco, Italy.
  • Albano D; Servizio di Medicina Nucleare, Humanitas Istituto Clinico Catanese, Misterbianco, Italy.
  • Dondi F; Servizio di Medicina Nucleare, Humanitas Istituto Clinico Catanese, Misterbianco, Italy.
  • Gusella S; Nuclear Medicine Unit, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.
  • Spimpolo A; Nuclear Medicine Unit, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.
  • Carriere C; Nuclear Medicine Unit, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.
  • Balma M; Nuclear Medicine Department, Central Hospital Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
  • Buschiazzo A; Nuclear Medicine Department, Central Hospital Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
  • Gallicchio R; Dermatology Department, Central Hospital Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
  • Storto G; Nuclear Medicine Unit, SC Medicina Nucleare, ASO S.Croce e Carle Cuneo, Cuneo, Italy.
  • Ruffini L; Nuclear Medicine Unit, SC Medicina Nucleare, ASO S.Croce e Carle Cuneo, Cuneo, Italy.
  • Scarlattei M; Nuclear Medicine Unit, IRCCS CROB Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
  • Baldari G; Nuclear Medicine Unit, IRCCS CROB Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
  • Cervino AR; Nuclear Medicine Division, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
  • Cuppari L; Nuclear Medicine Division, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
  • Burei M; Nuclear Medicine Division, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
  • Trifirò G; Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Brugola E; Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Zanini CA; Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Alessi A; Servizio di Medicina Nucleare ICS MAUGERI SPA SB-IRCCS, Pavia, Italy.
  • Fuoco V; Servizio di Medicina Nucleare ICS MAUGERI SPA SB-IRCCS, Pavia, Italy.
  • Seregni E; Department of Nuclear Medicine, Università Degli Studi di Milano, Milano Statale, Milan, Italy.
  • Deandreis D; Nuclear Medicine Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Liberini V; Nuclear Medicine Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Moreci AM; Nuclear Medicine Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ialuna S; Nuclear Medicine Division, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Pulizzi S; Nuclear Medicine Unit, SC Medicina Nucleare, ASO S.Croce e Carle Cuneo, Cuneo, Italy.
  • Evangelista L; Nuclear Medicine Division, Department of Medical Sciences, University of Turin, Turin, Italy.
Cancer Biother Radiopharm ; 38(4): 256-267, 2023 May.
Article en En | MEDLINE | ID: mdl-37098169
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Italia